Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Healthtrust
McKesson
Baxter
Covington

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 8,815,236

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,815,236
Title:Method for treating multiple sclerosis and crohn\'s disease
Abstract: A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, polysorbate 80, a buffer which inhibits polysorbate oxidation is described along with methods of making the preparation. Also described are formulations with high antibody concentrations which maintain fixed volumes and which may be used on patients of variable weight.
Inventor(s): Burke; David J. (Oakland, CA), Buckley; Shaun E. (San Francisco, CA), Lehrman; Sherwood Russ (Los Altos, CA), O\'Connor; Barbara Horsey (San Carlos, CA), Callaway; James (San Diego, CA), Phillips; Christopher P. (Doyleston, PA)
Assignee: Biogen Idec MA Inc. (Cambridge, MA)
Application Number:13/676,866
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,815,236
Patent Claims:see list of patent claims

Details for Patent 8,815,236

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Sign Up Biogen Idec MA Inc. (Cambridge, MA) 2023-02-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
QuintilesIMS
Boehringer Ingelheim
Johnson and Johnson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.